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Much attention has focused on potential
adverse health effects associated with expo-
sure to mercury and mercury compounds. Of
particular public health concern has been
possible neurologic impairment associated
with prolonged exposure to elemental mer-
cury (Hg0) vapor (Clarkson 2003; Echeverria
et al. 1998; Goering et al. 1992). Children
are known to be particularly vulnerable to
Hg0, prolonged exposure to which may cause
impairment of the developing central nervous
system, along with attendant personality,
motor function, and behavioral disorders
(Counter and Buchanan 2004; Davidson
et al. 2004; Levy et al. 2004).
A principal source of Hg0 exposure in
children is through dental amalgam ﬁllings,
which are approximately 50% metallic mer-
cury by weight. Hg0 vapors released from
amalgam ﬁllings in tooth surfaces are readily
absorbed into the systemic circulation by
inhalation (Berglund et al. 1988; Mackert
and Berglund 1997; Svare et al. 1981; Vimy
and Lorscheider 1985). Once absorbed, Hg0
undergoes biotransformation predominantly
in erythrocytes, to mercuric ion (Hg2+), the
ultimate mediator of mercury toxicity
(Halbach and Clarkson 1978; Magos et al.
1978). Debate continues as to the potential
adverse effects of low-level Hg0 exposure
from dental amalgam, particularly in children
(Brownawell et al. 2005; Clarkson and
Magos 2006).
Findings from two concurrently con-
ducted clinical trials that were designed to
evaluate the potential neurologic and neu-
robehavioral consequences of prolonged Hg0
exposure from dental amalgam fillings in
children have been recently reported
(Bellinger et al. 2006; DeRouen et al. 2006).
As part of one of those clinical trials
(DeRouen et al. 2006), we performed
annual measurements of urinary mercury
concentrations in children between 8 and 18
years of age as an assessment of longitudinal
exposure to Hg0 from amalgam fillings.
Here we describe changes in urinary mercury
levels in children with and without amalgam
ﬁllings over the course of the trial. We also
report age-, race-, and sex-related changes in
urinary mercury concentrations associated
with amalgam exposure.
Methods
Description of the study population and
details of dental treatments. Five hundred
seven children (54% boys, 46% girls) 8–10
years of age at baseline who were residents of
the Casa Pia school system in Lisbon,
Portugal, participated in a randomized,
prospective clinical trial to examine the
potential health effects of exposure to dental
amalgam tooth filling materials. Children
were evaluated at baseline and at seven subse-
quent annual intervals after initial dental
treatments with an extensive battery of neu-
robehavioral, neurologic, and renal function
assessments. The dental materials used in this
trial (amalgam or composite resin) were state-
of-the art, universally accepted tooth filling
materials. The choice of amalgam was the
brand most widely used in the United States,
Dispersalloy by Dentsply Caulk (York, PA,
USA), which, like most other brands, is
approximately 50% Hg0. All dental treat-
ments met existing standards of care in the
United States and Portugal. The study proto-
col was approved by the institutional review
boards at the University of Washington and
the University of Lisbon. All parents or
guardians gave written informed consent,
and all children provided signed assent. A
detailed description of the demographics of
the study population as well as the design
and methods employed has been previously
published (DeRouen et al. 2002).
Procedures for urine collection and meas-
uring urinary Hg and creatinine. A urine
sample (~ 50 mL) was collected from each
child at baseline and at each subsequently
scheduled annual visit to the University of
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BACKGROUND: Urinary mercury concentrations are widely used as a measure of mercury exposure
from dental amalgam fillings. No studies have evaluated the relationship of these measures in a
longitudinal context in children. 
OBJECTIVE: We evaluated urinary mercury in children 8–18 years of age in relation to number of
amalgam surfaces and time since placement over a 7-year course of amalgam treatment.
METHODS: Five hundred seven children, 8–10 years of age at baseline, participated in a clinical
trial to evaluate the neurobehavioral effects of dental amalgam in children. Subjects were random-
ized to either dental amalgam or resin composite treatments. Urinary mercury and creatinine con-
centrations were measured at baseline and annually on all participants.
RESULTS: Treatment groups were comparable in baseline urinary mercury concentration
(~ 1.5 µg/L). Mean urinary mercury concentrations in the amalgam group increased to a peak of
~ 3.2 µg/L at year 2 and then declined to baseline levels by year 7 of follow-up. There was a
strong, positive association between urinary mercury and both number of amalgam surfaces and
time since placement. Girls had significantly higher mean urinary mercury concentrations than
boys throughout the course of amalgam treatment. There were no differences by race in urinary
mercury concentration associated with amalgam exposure.
CONCLUSIONS: Urinary mercury concentrations are highly correlated with both number of amal-
gam ﬁllings and time since placement in children. Girls excrete signiﬁcantly higher concentrations
of mercury in the urine than boys with comparable treatment, suggesting possible sex-related dif-
ferences in mercury handling and susceptibility to mercury toxicity.
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tal, neurologic, and neurobehavioral evalua-
tions. Immediately after urine collection, a
10-mL aliquot was removed and acidified
with 1 N HCl. Analysis of total mercury
was performed using continuous flow, cold
vapor spectrofluorometry as previously
described (Pingree et al. 2001b). Urinary
creatinine concentrations were measured in
unacidified urine using a standard colori-
metric procedure (Sigma #555-A; Sigma-
Aldrich, St. Louis, MO, USA). Urinary
mercury levels were calculated as both
micrograms per gram creatinine and micro-
grams per liter urine. 
Statistical procedures. As a check on the
randomization procedure, we compared the
two treatment groups (amalgam or compos-
ite) in terms of the distributions of sex, race,
and baseline values of age, urinary mercury
concentration, urinary creatinine concentra-
tion, blood lead concentration, and IQ
(Figure 1 and Table 1). Mean values of mer-
cury concentration and creatinine-adjusted
mercury concentration were graphed by
treatment group and year, and treatment
group means were compared at each follow-
up year using t-tests. We used arithmetic
means for these analyses because of their ease
of interpretations; analyses of geometric
means (not shown) gave qualitatively similar
results. We compared treatment group
means ﬁrst for all study participants and then
separately for male and female participants.
We compared males and females within the
amalgam group using t-tests at each study
year. The amount of amalgam treatment was
characterized by the number of amalgam
surfaces placed at baseline (i.e., within 1 year
from the ﬁrst visit) and during the follow-up
period. Amalgam group participants were
classified according to baseline treatment
(0–4, 5–9, or > 9 surfaces) and follow-up
treatment (0, 1–9, or > 9 surfaces) (Table 2).
Mean urinary mercury concentrations for
each of the resulting nine subgroups were
then compared with means for the compos-
ite group as a whole. We used linear regres-
sion analysis to examine the prediction of
creatinine-adjusted urinary mercury concen-
tration (on the logarithmic scale) as a func-
tion of sex, race, baseline age, study year (as
categorical variable), number of amalgam
surfaces placed in ﬁrst year, number of amal-
gam surfaces placed in subsequent years, and
number of amalgam surfaces placed at base-
line that were subsequently lost due to tooth
exfoliation or extraction. An additional
analysis used weighted counts of surfaces
placed and lost, weighted for size of restora-
tion (1 = small, 2 = medium, 3 = large),
which gave qualitatively very similar results
(not reported). The method of generalized
estimating equations (Liang and Zeger 1986)
was used for this analysis to account for cor-
relation between observations on the same
subject in different years. The statistical
analyses used all available data, and missing
data on children who were not followed were
ignored. The main study conclusions were
not affected heavily by missing data, because
the latter pertain to the initial 5 years of
follow-up when missing was infrequent.
Statistical analyses were performed using
the statistical package R (version 2.4.1; R
Foundation for Statistical Computing,
Vienna, Austria).
Results
Baseline comparisons of treatment groups.
The treatment groups were similar in distrib-
ution of sex, race, baseline age, and baseline
urinary mercury concentration (Table 1).
The distributions of baseline urinary mer-
cury concentrations were very similar in the
two treatment groups (Figure 1). The groups
were also balanced on other baseline vari-
ables examined (DeRouen et al. 2006)
including average creatinine-adjusted urinary
mercury concentration (1.8 µg/g for the
amalgam group, and 1.9 µg/g for the com-
posite group), IQ score (85 and 85), blood
lead concentration (4.7 and 4.5 µg/dL),
number of carious surfaces (15.6 and 15.9),
Woods et al.
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Table 1. Demographics and baseline urinary mercury concentrations of the study participants by assigned
treatment group.
Variable Amalgam group (n = 253) Composite group (n = 254)
Sex
Female 116 (46) 112 (44)
Male 137 (54) 142 (56)
Race
White 178 (70) 181 (71)
Black 75 (30) 68 (27)
Asian 0 (0) 5 (2)
Baseline age (years) 10.1 ± 1.0 (8.0–12.4) 10.0 ± 0.9 (8.2–12.0)
Baseline urinary mercury  1.5 ± 1.2 (0.1–7.7) 1.4 ± 1.1 (0.0–8.6)
concentration (µg/L) 
Values are no. (%) or mean ± SD (range).
Table 2. Categorization of the amount of amalgam treatment at baseline (within the first year after the
initial visit) and during the follow-up period separately for male and female participants. 
Baseline amalgam Follow-up amalgam 
treatment treatment Male Female
(no. of surfaces) (no. of surfaces) [no. (%)] [no. (%)]
0–4 0 13 (9.5) 11 (9.5)
1–9 10 (7.2) 3 (2.6)
> 9 4 (2.9) 4 (3.4)
5–9 0 11 (8.0) 14 (12.1)
1–9 23 (16.8) 17 (14.7)
> 9 13 (9.5) 10 (8.6)
> 9 0 18 (13.1) 13 (11.2)
1–9 30 (21.9) 28 (24.1)
> 9 15 (10.9) 16 (13.8)
Total — 137 (100) 116 (100)
The amount of treatment during both time periods was similar for males and females.
Figure 1. Histograms of baseline urinary mercury concentrations in amalgam (A) and composite (B)
treated groups. Heights of the bars represent the numbers of subjects with values within the indicated
range. The distributions of baseline urinary mercury levels were similar in the two treatment groups.
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0and creatinine-adjusted albumin concentra-
tion (8.6 and 8.3 mg/g).
Follow-up mercury concentrations. Mean
urinary mercury concentrations in the amal-
gam group increased from approximately
1.5 µg/L at baseline to a peak of approxi-
mately 3.2 µg/L at year 2 and then slowly
declined to near baseline levels by year 7 of
follow-up (Figure 2). In contrast, mean mer-
cury concentrations changed very little in the
composite group throughout the 7-year fol-
low-up period. Differences between treat-
ment groups were highly significant at all
follow-up years except for the ﬁnal year. For
creatinine-adjusted mercury levels, group dif-
ferences were significant at all follow-up
years, including year 7 (Figure 2B). A possi-
ble reason for the lack of signiﬁcance at year 7
for unadjusted concentrations is the wide
confidence interval due to reduced sample
size and a small number of large values in the
composite group that increased the group
mean and SD. 
Race comparisons. Mean urinary mercury
concentrations for black and white partici-
pants were similar at baseline as well as
throughout all 7 years of follow-up. No sig-
nificant differences were found by race in
urinary mercury concentrations associated
with amalgam exposure (not shown).
Sex comparisons. Mean urinary mercury
concentrations for male and female partici-
pants were similar at baseline, but increases
after amalgam treatment were larger for
females than for males. As shown in Figure 3,
females who received amalgam fillings had
significantly higher mean urinary mercury
concentrations than males throughout the
7 years of follow-up. In contrast, there were
no differences in urinary mercury concentra-
tions between males and females in the com-
posite group. Mean mercury concentrations
for female amalgam group subjects reached a
peak of approximately 3.5 µg/L at year 2 and
remained about 3 µg/L throughout the 7-year
follow-up period. In contrast, mean mercury
values for males were < 3 µg/L at all years and
declined to the same level as seen in the com-
posite group by the end of follow-up. The
differences between males and females in uri-
nary mercury levels were not attributed to the
amount of treatment received. As indicated
in Table 2, the distributions of amalgam sur-
faces placed during baseline and follow-up
were similar for males and females. 
Dose–effect relationships. The increase in
urinary mercury concentrations was posi-
tively associated with the amount of amal-
gam treatment received at baseline and
during follow-up (Figure 4). The largest
increases in mercury concentrations (reach-
ing 3.1 µg/L in year 6) were observed in par-
ticipants receiving more than 9 amalgam
surfaces at baseline and an additional 10 or
more surfaces during follow-up. In contrast,
only small increases in urinary mercury con-
centrations were observed in participants
receiving 0–4 amalgam surfaces at baseline. 
Regression analysis. In regression analysis,
child sex (p < 0.001), baseline amalgam sur-
faces (p < 0.001), surfaces lost (p < 0.001),
and follow-up amalgam surfaces (p < 002)
were significant predictors of creatinine-
adjusted urinary mercury. Concentrations
for females were approximately 30% higher
than those for males [calculated as exp(0.25),
where 0.25 was the difference on the log
scale]. Each additional baseline surface was
associated with a 0.057 increase in concen-
tration on the log scale (corresponding to
about a 6% increase in concentration). Each
lost surface was associated with an increase
on 0.047 on the log scale; the difference
0.057–0.047 represents the effect of a surface
placed and then lost on urinary mercury
concentration. Each additional follow-up
surface was associated with an increase of
0.018 on the log scale. The effects of age and
race were not statistically signiﬁcant. 
Discussion
Numerous studies have described the rela-
tionship between mercury exposure from
dental amalgam restorations and its corre-
sponding excretion in the urine of adults
(Begerow et al. 1994; Dye et al. 2006;
Kingman et al. 1998; Mackert and Berglund
1997; Skare and Engqvist 1994) as well as
children (Gearhart et al. 1995; Khordi-
Mood et al. 2001; Levy et al. 2004; Pesch
et al. 2002; Suzuki et al. 1993). To our
knowledge, this is the ﬁrst study to describe
urinary mercury excretion patterns in chil-
dren during the longitudinal course of amal-
gam treatment from childhood through
adolescence and to quantify the relationship
between amalgam surfaces and urinary mer-
cury concentrations during the course of
treatment. The findings demonstrate a
strong, positive association between urinary
Urinary mercury from dental amalgam in children
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Figure 3. Mean urinary mercury concentrations for the amalgam group and composite group separately
for male (A) and female (B) participants. Error bars show 95% conﬁdence intervals for the group means.
Differences between males and females in the amalgam group were statistically signiﬁcant (p < 0.05) at all
follow-up years except follow-up year 3. The sex comparisons were not altered signiﬁcantly by adjustment
for creatinine (results not shown).
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Figure 2. Mean urinary mercury concentrations, unadjusted (A) and creatinine-adjusted (B), for the amal-
gam group and composite group. Error bars show 95% conﬁdence intervals for the group means. Group
differences were highly statistically significant (p < 0.001) for both measures at follow-up years 2
through 6. The group differences at year 7 were not signiﬁcant for unadjusted mercury (p = 0.07) but signif-
icant for adjusted mercury (p = 0.007).
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Compositemercury concentration and both number of
amalgam surfaces and time since placement.
Urinary mercury levels were highest approxi-
mately 2 years after initial amalgam treat-
ment, regardless of number of surfaces,
among children receiving no additional
fillings. Among children receiving up to 9
initial amalgam fillings, urinary mercury
concentrations returned to pretreatment
values within one year, consistent with a
whole-body biological half-time of mercury
on the order of 60–70 days (Clarkson et al.
1988). In contrast, for children receiving
≥ 10 amalgam fillings at baseline and with
no subsequent treatment, the decline from
peak to pretreatment urinary mercury con-
centrations occurred over a period of ≥ 3
years, consistent with the kinetics of a two-
compartment model of urinary mercury
elimination that predicts a substantially
longer whole-body mercury half-time
(Barregård et al. 1992). 
For children receiving > 9 additional
amalgam ﬁllings after initial amalgam place-
ment, urinary mercury concentrations
remained elevated 2- to 4-fold compared with
those of composite controls throughout much
of the 7-year follow-up, declining only gradu-
ally during this period. This was true regard-
less of the number of amalgam ﬁllings placed
at baseline. Nonetheless, data presented in
Figure 2 imply that the rate of urinary mer-
cury excretion exceeds the rate of mercury
exposure from dental amalgam in these sub-
jects at all time points. Notably, we observed a
constant but quantifiable urinary mercury
excretion among children in this study who
did not receive amalgam restorations, most
likely representing the systemic uptake of
mercury from food, air, and other environ-
mental sources. Together, these observations
imply that the level of mercury exposure from
all sources including amalgam ﬁllings did not
exceed the capacity for elimination via urinary
excretion in these subjects. That urinary out-
put increases approximately 1.5-fold between
10 and 15 years of age from approximately
1,000 to approximately 1,500 mL/24 hr
(Forfar and Arneil 1984) possibly contributes
to this capability, although previous reports
have suggested that the 24-hr urinary mercury
excretion rate is not signiﬁcantly inﬂuenced
by the urinary ﬂow rate (Skare and Engqvist
1990, 1994). 
Of particular interest was the finding
of significantly higher urinary mercury
concentrations in girls compared with boys
beginning with the ﬁrst year after initial amal-
gam placements and continuing through the
subsequent 7-year follow-up period. These
differences held up after adjustment for creati-
nine and differences in the amount of amal-
gam treatment received (Table 2). Factors
possibly accounting for this sex difference
include differences in a) eating habits, particu-
larly total time spent eating, and consumption
of hot beverages (Brune 1988), b) habitual
gum chewing (Gay et al. 1979), c) exercise
that results in high rates of breathing (Brune
1988), and d) body weight (Levy et al. 2004).
Variation in eating habits is not likely to con-
tribute to sex differences observed in the pre-
sent study, in that most subjects were enrolled
in the Casa Pia school system, which provided
the same meals to all children. Importantly,
ﬁsh consumption among participants in this
study was comparable and did not constitute
a significant source of mercury exposure
(Evens et al. 2001). Similarly, habitual gum
chewing, defined as chewing gum for the
greater part of every day, was relatively
uncommon within this population and not
likely to account for the sex differences
observed. In terms of body mass differences,
Levy et al. (2004) reported a significant
inverse relationship of urinary mercury con-
centration for children stratiﬁed on physical
characteristics such as height and weight.
However, no sex differences in urinary mer-
cury excretion were reported in that investiga-
tion. Although height and weight data were
not collected in the present study, no signiﬁ-
cant differences between boys and girls in cre-
atinine excretion—a surrogate measure of
body mass—were found over the course of
follow-up (Martin MD, unpublished data),
suggesting a more predominant effect of sex
per se as opposed to body size or exercise rates
on the mercury excretion differences observed
in this study. 
Sex differences in mercury handling in
both animals and humans have been
described. In terms of inorganic mercury,
Hultman and Nielsen (2001) reported signiﬁ-
cantly greater whole-body mercury retention
as well as greater mercury accumulation in kid-
neys and spleens of male compared with
female mice of several strains during prolonged
exposure to mercuric chloride. In human stud-
ies, women were reported to have signiﬁcantly
higher urinary mercury concentrations than
men with comparable numbers of dental
amalgam ﬁllings (Akesson et al. 1991), similar
to ﬁndings here. Studies on the excretion of
organic and inorganic mercury in methylmer-
cury-treated rats (Thomas et al. 1987) showed
faster whole-body clearance of mercury in
Woods et al.
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Figure 4. The increase in urinary mercury concentration is inﬂuenced by both the amount and timing of amalgam treatment. Children in the amalgam group were
categorized according to the number of amalgam surfaces placed at baseline—(A) 0–4; (B) 5–9; (C) > 9—and the number of additional amalgam surfaces placed
in subsequent years. The values plotted are the differences between mean urinary mercury in a particular subgroup of amalgam-treated children compared with
mean urinary mercury concentration in the composite group at each year. 
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females than in males, also consistent with the
present ﬁndings. Similarly, studies on methyl-
mercury exposure in human infants and
children (Grandjean et al. 1988; McKeown-
Eyssen et al. 1983) as well as animals
(Gimenez-Llort et al. 2001; Rossi et al. 1997)
reported greater developmental effects in males
than in females, consistent with higher overall
mercury retention and lower rates of mercury
excretion by males. Although numerous fac-
tors that might differentially affect mercury
disposition have been reported (Vahter et al.
2007), the biological mechanisms underlying
sex-related differences in mercury excretion
rates or susceptibility to mercury toxicity
remain to be identiﬁed. Inasmuch as there are
no known sex differences in humans with
regard to the urine formation rate by the kid-
neys, the present findings imply a greater
degree of mercury retention by males, possibly
consistent with higher tissue levels observed in
some studies. 
Questions arise from the present observa-
tions as to the interpretation of urinary mer-
cury concentrations in the assessment of safe
mercury exposure levels. If girls are, in fact,
more proﬁcient in the excretion of mercury
than boys, then it may follow that a speciﬁc
urinary mercury concentration measured in
girls represents a lesser risk of mercury toxicity
than the same urinary concentration in boys.
This issue speaks directly to the question of
differential sensitivity (Brent and Weitzman
2004; Makre et al. 1986) and the establish-
ment of precautionary measures directed at
protecting the most susceptible from risks of
mercury toxicity or mercury-associated disor-
ders in children (U.S. Environmental
Protection Agency 2000). Toxicokinetic stud-
ies that identify underlying sex-related differ-
ences in mercury handling and the use of
metabolic biomarkers that reflect mercury
body and tissue burden (Bowers et al. 1992;
Pingree et al. 2001a; Woods 1995; Woods
et al. 1993) may be useful in these endeavors.
In conclusion, in the present study we
describe a strong, positive correlation
between mercury exposure from dental amal-
gam fillings and urinary mercury excretion
over a 7-year longitudinal course of amalgam
treatment in children. However, significant
differences in urinary mercury concentrations
between boys and girls with comparable lev-
els of amalgam treatment and times since
placement suggest sex-related differences in
mercury handling and, possibly, susceptibility
to mercury toxicity. These ﬁndings are rele-
vant within the context of children’s health
risk assessment and suggest directions for
future research to determine whether differ-
ential sensitivities to mercury between boys
and girls do exist.
REFERENCES
Akesson I, Schutz A, Attewell R, Skerfving S, Glantz P-O. 1991.
Status of mercury and selenium in dental personnel:
impact of amalgam work and own fillings. Arch Environ
Health 46:102–109. 
Barregård L, Sällsten G, Schütz A, Attewell R, Skerfving S,
Järvholm B. 1992. Kinetics of mercury in blood and urine after
brief occupational exposure. Arch Environ Health 47:176–184.
Begerow J, Zander D, Freier I, Dunemann L. 1994. Long-term
mercury excretion in urine after removal of amalgam fill-
ings. Int Arch Occup Environ Health 66:209–212.
Bellinger DC, Trachtenberg T, Barregard L, Tavares M,
Cernichiari E, Daniel D, et al. 2006. Neuropsychological
and renal effects of dental amalgam in children: a random-
ized clinical trial, JAMA 295:1775–1783.
Berglund A, Pohl L Olsson S, Bergman M. 1988. Determination
of the rate of release of intra-oral mercury vapor from
amalgam. J Dent Res 67:1235–1242.
Bowers MA, Aicher LD, Davis HA, Woods JS. 1992.
Quantitative determination of porphyrins in rat and human
urine and evaluation of urinary porphyrin profiles during
mercury and lead exposures. J Lab Clin Med 120:272–281.
Brent RL, Weitzman M. 2004. The current state of knowledge
about the effects, risks, and science of children’s environ-
mental exposures. Pediatrics 113:1158–1166.
Brownawell AM, Berent S, Brent RL, Bruckner JV, Doull J,
Gershwin EM, et al. 2005. The potential adverse health
effects of dental amalgam. Toxicol Rev 24:1–10.
Brune D. 1988. Mechanisms and kinetics of metal release from
dental alloys. Int Endod J 21:135–142.
Clarkson TW. 2003. Three modern faces of mercury. Environ
Health Perspect 110:11–23.
Clarkson TW, Friberg L, Hursh JB, Nylander M. 1988. The pre-
diction of intake of mercury vapor from amalgams. In:
Biological Monitoring of Toxic Metals (Clarkson TW,
Friberg L, Nordberg GF, Sager PR, eds). New York:Plenum
Press, 247–264.
Clarkson TW, Magos L. 2006. The toxicology of mercury and its
chemical compounds. Crit Rev Toxicol 36:609–662.
Counter SA, Buchanan LH. 2004 Mercury exposure in children:
a review. Toxicol Appl Pharmacol 198:229–230.
Davidson PW, Myers GJ, Weiss B. 2004. Mercury exposure
and child development outcomes. Pediatrics 113(suppl
4):1023–1029.
DeRouen TA, Leroux BG, Martin MD, Townes BD, Woods JS,
Leitão J, et al. 2002. Issues in the design and analysis of a
randomized clinical trial to assess the safety of dental amal-
gam restorations in children. Contr Clin Trials 23:301–320.
DeRouen TA, Martin MD, Leroux BG, Townes BD, Woods JS,
Leitão J, et al. 2006. Neurobehavioral effects of dental
amalgam in children. JAMA 295:1784–1792. 
Dye BA, Schober SE, Dillon CF, Jones RL, Fryar C, McDowell
M, et al. 2006. Urinary mercury concentrations associated
with dental restorations in adult women aged 16–49 years:
United States, 1999-2000. Occup Environ Med 62:368–375.
Echeverria D, Aposhian HV, Woods JS, Heyer NJ, Aposhian
MM, Bittner AC, et al. 1998. Neurobehavioral effects from
exposure to dental amalgam: new distinctions between
recent exposure and Hg body burden. FASEB J 12:971–980.
Evens CC, Martin MD, Woods JS, Soares HL, Bernardo M, Leitão
J, et al. 2001. Examination of dietary methylmercury expo-
sure in the Casa Pia study of the health effects of dental
amalgams in children. J Toxicol Environ Health 64:521–530.
Forfar JA, Arneil GC, eds. 1984. Textbook of Pediatrics. 3rd ed.
New York:Churchill Livingstone.
Gay DD, Cox RD, Reinhart JW. 1979. Chewing releases mercury
from ﬁllings. Lancet 1:985–986.
Gearhart JM, Clewell JH III, Crump KS, Shipp AM, Silvers A.
1995. Pharmacokinetic dose estimates of mercury in chil-
dren and dose-response curves of performance tests in a
large epidemiological study. Water Air Soil Poll 80:49–58.
Gimenez-Llort L, Ahlbom D, Daré E, Vahter M, Ogren S,
Ceccatelli S. 2001. Prenatal exposure to methylmercury
changes dopamine-modulated motor activity during early
ontogeny: age and gender-dependent effects. Environ
Toxicol Pharmacol 9:61–70.
Goering PL, Galloway WD, Clarkson TW, Lorscheider FL, Berlin
M, Rowland AS. 1992. Toxicity assessment of mercury vapor
from dental amalgams. Fundam Appl Toxicol 19:319–329.
Grandjean P, Weihe P, White RF, Debes F. 1998. Cognitive
performance of children preferentially exposed to “safe”
levels of methylmercury. Environ Res 77:165-172.
Halbach S, Clarkson TW. 1978. Enzymatic oxidation of mercury
vapor by erythrocytes. Biochim Biophys Acta 523:522–531.
Hultman P, Nielsen JB. 2001. The effect of dose, gender, and
non-H-2 genes in murine mercury-induced autoimmunity.
J Autoimmun 17:27–37.
Khordi-Mood M, Sarraf-Shirazi A, Balali-Mood M. 2001. Urinary
mercury excretion following amalgam filling in children.
Clin Toxicol 39:701–705. 
Kingman A, Albertini T , Brown LJ. 1998. Mercury concentra-
tions in urine and whole blood associated with amalgam
exposure in a US military population J Dent Res 77:461–467.
Levy M, Schwartz S, Dijak M, Weber J-P, Tardif R, Rouah F.
2004. Childhood urine mercury excretion: dental amalgam
and fish consumption as exposure factors. Environ Res
94:283–290.
Liang K-Y, Zeger SL. 1986. Longitudinal data analysis using
generalized linear models. Biometrika 73:13–22.
Mackert JR Jr., Bergland A. 1997. Mercury exposure from den-
tal amalgam fillings: absorbed dose and the potential for
adverse health effects. Crit Rev Oral Med 8:410–436.
Magos L, Halbach S, Clarkson TW. 1978. Role of catalase in the oxi-
dation of mercury vapor. Biochem Pharmacol 27:1373–1377.
Makre G, Balbus J, Parkin R. 1986. Children’s susceptibility to
chemicals: a review by developmental stage. J Toxicol
Environ Health 7:417–436.
McKeown-Eyssen GE, Ruedy J, Neims A. 1983. Methyl mercury
exposure in northern Quebec. II. Neurologic findings in
children. Amer J Epidemiol 118:470–479.
Pesch A, Wilhelm M, Rostek U, Schmitz N, Weishoff-Houben
M, Ranft U, et al. 2002. Mercury concentrations in urine,
scalp hair, and saliva in children from Germany. J Expo
Anal Environ Epidemiol 12:252-258.
Pingree SD, Simmonds PL, Rummel KT, Woods JS. 2001a.
Quantitative evaluation of urinary porphyrins as a measure
of kidney mercury content and mercury body burden dur-
ing prolonged methylmercury exposure in rats. Toxicol Sci
61:234–240.
Pingree SD, Simmonds PL, Woods JS. 2001b. Effects of
2,3-dimercapto-1-propanesulfonic acid (DMPS) on tissue
and urine mercury levels following prolonged methylmer-
cury exposure in rats. Toxicol Sci 61:224–233.
Rossi AD, Ahlbom E, Ogren SO, Nicotera P, Ceccatelli S. 1997.
Prenatal exposure to methylmercury alters locomotor
activity of male but not female rats. Exp Brain Res
117:428–436.
Skare I, Engqvist A. 1990. Urinary mercury clearance of dental
personnel after a long-term intermission in occupational
exposure. Swed Dent J 14:255–259.
Skare I, Engqvist A. 1994. Human exposure to mercury and sil-
ver released from dental amalgam restorations. Arch
Environ Health 49:384–394.
Svare CW, Paterson LC, Reinhardt JW, Boyer DB, Frank CW,
Gay DD, et al. 1981. The effect of dental amalgam on mer-
cury levels in expired air. J Dent Res 60:1668–1671.
Suzuki T, Hongo T, Abe T, Matsuo N, Inoue N. 1993. Urinary
mercury levels in Japanese school children: influence of
dental amalgam fillings and fish eating habits. Sci Total
Environ 136:213–227.
Thomas DJ, Fisher HL, Sumler MR, Mushak P, Hall ll. 1987.
Sexual differences in the excretion of organic and inor-
ganic mercury by methyl mercury-treated rats. Environ
Res 43:203–216.
U.S. Environmental Protection Agency. 2000. Strategy for
Research on Environmental Risks to Children. EPA/600/R-
00/068. Washington, DC:U.S. Environmental Protection
Agency.
Vahter M, Åkesson A, Lidén C, Seccatelli S, Berglund M. 2007.
Gender differences in the disposition and toxicity of met-
als. Environ Res 104:85–95.
Vimy MJ, Lorscheider FL. 1985. Intra-oral air mercury released
from dental amalgam. J Dent Res 64:1069–1071.
Woods JS. 1995. Porphyrin metabolism as indicator of metal expo-
sure and toxicity: In: Handbook of Experimental Pharma-
cology: Toxicology of Metals—Biochemical Aspects (Goyer
RA, Cherian MG, eds). Berlin:Springer-Verlag, 115:19–52.
Woods JS, Martin MD, Naleway CA, Echeverria D. 1993. Urinary
porphyrin profiles as a biomarker of mercury exposure:
studies in dentists with occupational exposure to mercury
vapor. J Toxicol Environ Health 40:235–246.